Long non-coding RNAs BACE1-AS and BC200 in multiple sclerosis and their relation to cognitive function: A gene expression analysis A Kamal, M Swellam, NM Shalaby, MK Darwish, EM El-Nahrery Brain Research 1814, 148424, 2023 | 6 | 2023 |
Cannabinoids and multiple sclerosis: a critical analysis of therapeutic potentials and safety concerns RA Nouh, A Kamal, A Abdelnaser Pharmaceutics 15 (4), 1151, 2023 | 4 | 2023 |
Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine RA Nouh, A Kamal, O Oyewole, WA Abbas, B Abib, A Omar, ST Mansour, ... Pharmaceutics 16 (2), 241, 2024 | 1 | 2024 |
Silent players, loud impact: unveiling the therapeutic potentials of lncRNAs A Kamal, M Swellam, NM Shalaby, MK Darwish, EM El-Nahrery | | 2024 |
Neurotrophic Long Non-Coding RNAs and Multiple Sclerosis A Kamal, MM Swellam, NM Shalaby, MK Darwish, I El-Nahrery BIOCHEMISTRY AND CELL BIOLOGY 101 (6), 2023 | | 2023 |
BDNF-AS is a promising downregulated biomarker for the diagnosis in different disease types in multiple sclerosis A Kamal, MM Swellam, NM Shalaby, MK Darwish, I El-Nahrery Research Square Preprint, 2022 | | 2022 |